Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Affiliations

• ¹ Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
• ² Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
• ³ Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
• ⁴ University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
• ⁵ College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
• ⁶ Centre pour le Développement des Vaccins, Bamako, Mali.
• ⁷ INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
• ⁸ National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
• ⁹ REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
• ¹⁰ Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
• ¹¹ London School of Hygiene & Tropical Medicine, London, UK.
• ¹² AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France.
• ¹³ REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France. [email protected].
• ¹⁴ AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France. [email protected].